Company Filing History:
Years Active: 2018
Title: Gunter Weiss: Innovator in Predictive Medicine
Introduction
Gunter Weiss is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of predictive medicine, particularly in the treatment of cell proliferative disorders. His innovative work has the potential to improve patient outcomes through advanced genetic analysis.
Latest Patents
Gunter Weiss holds a patent for "Markers for the prediction of outcome of anthracycline treatment." This invention relates to methods for predicting the effectiveness of anthracycline treatment in patients with cell proliferative disorders. The prediction is achieved by determining the expression level of specific genes, including PITX2, TFF1, and PLAU. The patent also encompasses sequences, oligonucleotides, and antibodies that can be utilized within these methods. He has 1 patent to his name.
Career Highlights
Throughout his career, Gunter Weiss has worked with various companies, including Therawis Diagnostics GmbH and Epigenomics AG. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Gunter Weiss has collaborated with notable professionals in his field, including John Foekens and John W. Martens. These collaborations have contributed to the advancement of his research and the successful development of his inventions.
Conclusion
Gunter Weiss is a distinguished inventor whose work in predictive medicine is paving the way for improved treatment outcomes in patients. His innovative patent and collaborations highlight his commitment to advancing medical science.